-
-
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Transrectal Ultrasound Market Size, Share & Trends Analysis Report By Product Type (Portable and Cart / Trolley-based), Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound, and Others), Application (Diagnostic [Benign Prostatic Hyperplasia, Prostate Cancer Diagnosis, Others] and Image-guided Biopsy), End-user (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others),- Market Outlook And Industry Analysis 2035″
Transrectal Ultrasound Market Size is valued at USD 280.56 Mn in 2025 and is predicted to reach USD 526.45 Mn by the year 2035 at a 6.6% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3471
Transrectal ultrasound (TRUS) is a diagnostic imaging technique used to produce high-resolution visualizations of pelvic anatomy, with primary application in the evaluation of the prostate gland. It is commonly employed in combination with ultrasound-guided needle biopsy procedures for patients exhibiting elevated prostate-specific antigen (PSA) levels or abnormal findings during digital rectal examinations.
TRUS-guided biopsies are integral to the diagnosis of conditions such as prostatitis, benign prostatic hyperplasia, and prostate cancer. The global TRUS market is demonstrating strong growth, supported by an aging population, favorable reimbursement structures, increasing procedural volumes, rising incidence of prostate cancer, and heightened awareness regarding the importance of early detection and screening.
Technological advancements continue to enhance the clinical effectiveness and diagnostic precision of TRUS. The adoption of high-definition imaging systems has significantly improved image clarity, enabling more accurate identification of suspicious lesions. Furthermore, the integration of MRI-ultrasound fusion technology—combining pre-procedural magnetic resonance imaging with real-time TRUS guidance—facilitates targeted biopsy of clinically relevant lesions, thereby improving cancer detection rates while reducing unnecessary sampling of benign tissue. The incorporation of artificial intelligence is further advancing the modality by supporting image analysis, lesion identification, and procedural guidance. Collectively, these innovations are strengthening the role of TRUS as a fundamental diagnostic tool while expanding its clinical applications.
Read Comprehensive Report Overview: https://www.insightaceanalytic.com/report/transrectal-ultrasound-market/3471
List of Prominent Players in the Transrectal Ultrasound Market:
- Siemens Healthineers AG
- GE Healthcare
- KOELIS
- FUJIFILM Corporation
- Telemed Medical Systems
- Exact Imaging
- Koninklijke Philips N.V.
- Mindray Medical International Limited
- Hitachi Medical Systems
- Strata Imaging
- Others
Market Dynamics
Drivers:
The global transrectal ultrasound (TRUS) market is primarily supported by the rising incidence of prostate-related disorders, including benign prostatic hyperplasia (BPH) and prostate cancer. Increasing awareness of these conditions has intensified the demand for early diagnosis and reliable imaging solutions, positioning TRUS as an effective and minimally invasive diagnostic modality. Technological advancements in ultrasonography, such as improved image resolution and reduced procedure times, are further enhancing clinical efficiency and supporting market expansion. Additionally, the growing geriatric population—more vulnerable to prostate-related conditions—continues to drive the adoption of TRUS across healthcare settings.
Challenges:
Despite its clinical benefits, the market faces several constraints. The high cost associated with advanced ultrasound equipment, along with expenses related to maintenance and system upgrades, poses a financial challenge, particularly for smaller healthcare providers. Moreover, the technical complexity of TRUS procedures necessitates specialized training, and the limited availability of skilled professionals may restrict broader utilization. These factors contribute to disparities in access and adoption across healthcare systems, thereby limiting overall market growth.
Regional Trends:
North America held the largest share of the transrectal ultrasound market in 2025, supported by a high prevalence of prostate disorders in countries such as United States and Canada. The region benefits from a well-developed healthcare infrastructure, widespread access to advanced diagnostic technologies, and a large aging population with strong awareness of early screening practices. The increasing use of TRUS-guided biopsy procedures in urology, coupled with a preference for minimally invasive diagnostics, is further driving market growth. Favorable reimbursement policies, continuous technological advancements—including fusion biopsy systems and advanced 3D/4D imaging—and the presence of leading medical device manufacturers are also contributing to sustained regional expansion.
The Asia-Pacific region is projected to witness the fastest growth during the forecast period, driven by rising awareness of prostate health, population growth, and increasing healthcare expenditure. Government initiatives aimed at improving healthcare accessibility and quality are playing a pivotal role, particularly in emerging economies. Countries such as China and Japan dominate the regional market, while India and South Korea are also contributing significantly. The presence of key market participants focusing on cost-effective innovations, along with ongoing expansion of healthcare infrastructure and adoption of advanced imaging technologies, is expected to further accelerate market development across the region.
Add our site to Google Preferred Sources for quality content: https://google.com/preferences/source?q=insightaceanalytic.com
Segmentation of Transrectal Ultrasound Market-
By Product Type-
- Portable
- Cart / Trolley-based
By Technology –
- 2D Ultrasound
- 3D Ultrasound
- 4D Ultrasound
- Others
By Application-
- Diagnostic
- Benign Prostatic Hyperplasia
- Prostate Cancer Diagnosis
- Others
- Image-guided Biopsy
By End-user-
- Hospitals
- Specialty Clinics
- Diagnostic Imaging Centers
- Others
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Customize this Study according to your Requirements @ https://www.insightaceanalytic.com/customization/3471
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
